Lipocine Inc.
LPCN
$3.10
$0.082.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.27% | -204.64% | 180.32% | 27.69% | -187.33% |
| Total Depreciation and Amortization | 3.21% | 0.00% | 83.53% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.63% | 155.41% | 88.35% | -1,965.63% | 87.28% |
| Change in Net Operating Assets | 305.43% | -82.28% | 82.84% | -174.19% | 155.04% |
| Cash from Operations | 4.22% | -215.71% | 160.08% | -13.42% | -203.75% |
| Capital Expenditure | -- | -- | 87.52% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 610.15% | -214.40% | -30.06% | -76.80% | 216.20% |
| Cash from Investing | 610.15% | -215.90% | -25.56% | -78.48% | 216.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Financing | -- | -- | -- | -100.00% | 2,783.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 194.32% | -215.77% | 236.05% | -173.24% | 246.24% |